NCT03227484View on ClinicalTrials.gov

Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 9, 2017

Primary Completion Date

October 25, 2019

Study Completion Date

November 18, 2019

Conditions
PreDiabetesBody Weight
Interventions
DRUG

Empagliflozin 25mg

Once daily over 8 weeks

DRUG

Placebo Oral Tablet

Once daily over 8 weeks

Trial Locations (1)

72076

University of Tuebingen, Department of Internal Medicine IV, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT03227484 - Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes | Biotech Hunter | Biotech Hunter